131 related articles for article (PubMed ID: 22884782)
1. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
2. No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.
Kimer N; Gudmann NS; Pedersen JS; Møller S; Nielsen MJ; Leeming DJ; Karsdal MA; Møller HJ; Bendtsen F; Grønbæk H
PLoS One; 2018; 13(9):e0203200. PubMed ID: 30183743
[TBL] [Abstract][Full Text] [Related]
3. Serum-Soluble CD163 Levels as a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma Treated with Chemoimmunotherapy.
Koudouna A; Gkioka AI; Gkiokas A; Tryfou TM; Papadatou M; Alexandropoulos A; Bartzi V; Kafasi N; Kyrtsonis MC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474108
[TBL] [Abstract][Full Text] [Related]
4. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumour growth and increases survival in the murine EL4 model.
Dey S; Vieyra-Garcia PA; Joshi AA; Trajanoski S; Wolf P
Front Immunol; 2024; 15():1255859. PubMed ID: 38646524
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD163: a novel independent prognostic biomarker in patients with metastatic renal cell carcinoma.
Lauridsen KM; Hokland M; Al-Karradi S; Møller HJ; Donskov F; Andersen MN
Cancer Immunol Immunother; 2023 Feb; 72(2):461-473. PubMed ID: 35953682
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota analyses of cutaneous T-cell lymphoma patients undergoing narrowband ultraviolet B therapy reveal alterations associated with disease treatment.
Nguyen WQ; Chrisman LP; Enriquez GL; Hooper MJ; Griffin TL; Ahmad M; Rahman S; Green SJ; Seed PC; Guitart J; Burns MB; Zhou XA
Front Immunol; 2023; 14():1280205. PubMed ID: 38274799
[TBL] [Abstract][Full Text] [Related]
8. CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM.
Sun H; Wang ZY; Han Y; Wei XJ; Wang YC; Yu XF
Ann Clin Transl Neurol; 2024 May; 11(5):1267-1279. PubMed ID: 38651547
[TBL] [Abstract][Full Text] [Related]
9. Macrophage immunophenotypes in Jorge Lobo's disease and lepromatous leprosy- A comparative study.
Sasso BM; Vallarelli A; Rosa PS; Belone A; Velho P; Cintra ML
Microb Pathog; 2024 May; 190():106610. PubMed ID: 38484920
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of psoriasis and cutaneous T-cell lymphoma.
Scott J; Lai C; Coltart G; Bates A; Bennett L; Sommerlad M; Foria V; Healy E
Clin Exp Dermatol; 2023 Sep; 48(10):1155-1159. PubMed ID: 37379526
[TBL] [Abstract][Full Text] [Related]
11. New Genetic Markers of Skin T-Cell Lymphoma Treatment.
Vašků V; Fialová P; Vašků A
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540417
[TBL] [Abstract][Full Text] [Related]
12. Multi-omic profiling reveals the endogenous and neoplastic responses to immunotherapies in cutaneous T cell lymphoma.
Glass DR; Mayer-Blackwell K; Ramchurren N; Parks KR; Duran GE; Wright AK; Bastidas Torres AN; Islas L; Kim YH; Fling SP; Khodadoust MS; Newell EW
Cell Rep Med; 2024 May; 5(5):101527. PubMed ID: 38670099
[TBL] [Abstract][Full Text] [Related]
13. Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.
Hasan I; Parsons L; Duran S; Zinn Z
J Am Acad Dermatol; 2024 Apr; ():. PubMed ID: 38588818
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA sequencing analysis of vestibular schwannoma reveals functionally distinct macrophage subsets.
Baruah P; Mahony C; Marshall JL; Smith CG; Monksfield P; Irving RI; Dumitriu IE; Buckley CD; Croft AP
Br J Cancer; 2024 Jun; 130(10):1659-1669. PubMed ID: 38480935
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional iron metabolism in pressure injuries is related to aberrant CD163 and Homx-1 signal transduction.
Zhang J; Shan H; Guo J; Wang X; Wang W
Wound Repair Regen; 2024; 32(3):268-278. PubMed ID: 38148566
[TBL] [Abstract][Full Text] [Related]
16. Immune cells in skin inflammation, wound healing, and skin cancer.
Zhang Y; Lu Q
J Leukoc Biol; 2024 Apr; 115(5):852-865. PubMed ID: 37718697
[TBL] [Abstract][Full Text] [Related]
17. DMF in CTCL: where do we go from here?
Allen PB
Blood; 2023 Aug; 142(9):753-754. PubMed ID: 37651156
[No Abstract] [Full Text] [Related]
18. The role of IL-32 in cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Kawaguchi M; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Invest Dermatol; 2014 May; 134(5):1428-1435. PubMed ID: 24226419
[TBL] [Abstract][Full Text] [Related]
19. Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.
Wu X; Schulte BC; Zhou Y; Haribhai D; Mackinnon AC; Plaza JA; Williams CB; Hwang ST
J Invest Dermatol; 2014 Nov; 134(11):2814-2822. PubMed ID: 24780929
[TBL] [Abstract][Full Text] [Related]
20. Narrowband UVB as an effective substitute for psoralen plus UVA: lessons from a psoralen shortage.
Drucker AM; Baibergenova A; Rosen CF; Shear NH
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):267-8. PubMed ID: 22971194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
